Jiamin Guo1,2, Yanzhong Yang3, Ralf Buettner1, Steven T Rosen1. 1. Hematology Malignancies and Stem Cell Transplantation Institute, Gehr Family Center for Leukemia Research. 2. Irell & Manella Graduate School of Biological Sciences. 3. Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope National Cancer Center, Duarte, California, USA.
Abstract
PURPOSE OF REVIEW: In this review, we summarize the biological roles of methionine, methionine adenosyl transferase 2A (MAT2A) and S -adenosyl methionine (SAM) in methylation reactions during tumorigenesis. Newly emerged inhibitors targeting the methionine-MAT2A-SAM axis will be discussed. RECENT FINDINGS: SAM is the critical and global methyl-donor for methylation reactions regulating gene expression, and in mammalian cells, it is synthesized by MAT2A using methionine. Recent studies have validated methionine and MAT2A as metabolic dependencies of cancer cells because of their essential roles in SAM biosynthesis. MAT2A inhibition leads to synthetic lethality in methylthioadenosine-phosphorylase (MTAP)-deleted cancers, which accounts for 15% of all cancer types. Of note, remarkable progress has been made in developing inhibitors targeting the methionine-MAT2A-SAM axis, as the first-in-class MAT2A inhibitors AG-270 and IDE397 enter clinical trials to treat cancer. SUMMARY: The methionine-MAT2A-SAM axis plays an important role in tumorigenesis by providing SAM as a critical substrate for abnormal protein as well as DNA and RNA methylation in cancer cells. Targeting SAM biosynthesis through MAT2A inhibition has emerged as a novel and promising strategy for cancer therapy.
PURPOSE OF REVIEW: In this review, we summarize the biological roles of methionine, methionine adenosyl transferase 2A (MAT2A) and S -adenosyl methionine (SAM) in methylation reactions during tumorigenesis. Newly emerged inhibitors targeting the methionine-MAT2A-SAM axis will be discussed. RECENT FINDINGS: SAM is the critical and global methyl-donor for methylation reactions regulating gene expression, and in mammalian cells, it is synthesized by MAT2A using methionine. Recent studies have validated methionine and MAT2A as metabolic dependencies of cancer cells because of their essential roles in SAM biosynthesis. MAT2A inhibition leads to synthetic lethality in methylthioadenosine-phosphorylase (MTAP)-deleted cancers, which accounts for 15% of all cancer types. Of note, remarkable progress has been made in developing inhibitors targeting the methionine-MAT2A-SAM axis, as the first-in-class MAT2A inhibitors AG-270 and IDE397 enter clinical trials to treat cancer. SUMMARY: The methionine-MAT2A-SAM axis plays an important role in tumorigenesis by providing SAM as a critical substrate for abnormal protein as well as DNA and RNA methylation in cancer cells. Targeting SAM biosynthesis through MAT2A inhibition has emerged as a novel and promising strategy for cancer therapy.
Authors: Elena Strekalova; Dmitry Malin; Erin M M Weisenhorn; Jason D Russell; Dominik Hoelper; Aayushi Jain; Joshua J Coon; Peter W Lewis; Vincent L Cryns Journal: Breast Cancer Res Treat Date: 2019-02-02 Impact factor: 4.872
Authors: Ben Murray; Svetlana V Antonyuk; Alberto Marina; Shelly C Lu; Jose M Mato; S Samar Hasnain; Adriana L Rojas Journal: Proc Natl Acad Sci U S A Date: 2016-02-08 Impact factor: 11.205
Authors: Zenon Konteatis; Jeremy Travins; Stefan Gross; Katya Marjon; Amelia Barnett; Everton Mandley; Brandon Nicolay; Raj Nagaraja; Yue Chen; Yabo Sun; Zhixiao Liu; Jie Yu; Zhixiong Ye; Fan Jiang; Wentao Wei; Cheng Fang; Yi Gao; Peter Kalev; Marc L Hyer; Byron DeLaBarre; Lei Jin; Anil K Padyana; Lenny Dang; Joshua Murtie; Scott A Biller; Zhihua Sui; Kevin M Marks Journal: J Med Chem Date: 2021-04-08 Impact factor: 7.446
Authors: Yingjie Bian; Wei Li; Daniel M Kremer; Peter Sajjakulnukit; Shasha Li; Joel Crespo; Zeribe C Nwosu; Li Zhang; Arkadiusz Czerwonka; Anna Pawłowska; Houjun Xia; Jing Li; Peng Liao; Jiali Yu; Linda Vatan; Wojciech Szeliga; Shuang Wei; Sara Grove; J Rebecca Liu; Karen McLean; Marcin Cieslik; Arul M Chinnaiyan; Witold Zgodziński; Grzegorz Wallner; Iwona Wertel; Karolina Okła; Ilona Kryczek; Costas A Lyssiotis; Weiping Zou Journal: Nature Date: 2020-09-02 Impact factor: 49.962